161 related articles for article (PubMed ID: 37908718)
1. Universal theranostic CRISPR/Cas13a RNA-editing system for glioma.
Wu Y; Wang Y; Zhou J; Wang J; Zhan Q; Wang Q; Yang E; Jin W; Tong F; Zhao J; Hong B; Liu J; Kang C
Theranostics; 2023; 13(15):5305-5321. PubMed ID: 37908718
[No Abstract] [Full Text] [Related]
2. Specific High-Sensitivity Enzymatic Molecular Detection System Termed RPA-Based CRISPR-Cas13a for Duck Tembusu Virus Diagnostics.
He D; Liu G; Yang J; Jiang X; Wang H; Fan Y; Gong S; Wei F; Diao Y; Tang Y
Bioconjug Chem; 2022 Jun; 33(6):1232-1240. PubMed ID: 35586918
[TBL] [Abstract][Full Text] [Related]
3. High-Fidelity and Rapid Quantification of miRNA Combining crRNA Programmability and CRISPR/Cas13a trans-Cleavage Activity.
Shan Y; Zhou X; Huang R; Xing D
Anal Chem; 2019 Apr; 91(8):5278-5285. PubMed ID: 30873832
[TBL] [Abstract][Full Text] [Related]
4. The CRISPR-Cas13a Gene-Editing System Induces Collateral Cleavage of RNA in Glioma Cells.
Wang Q; Liu X; Zhou J; Yang C; Wang G; Tan Y; Wu Y; Zhang S; Yi K; Kang C
Adv Sci (Weinh); 2019 Oct; 6(20):1901299. PubMed ID: 31637166
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical self-uncloaking CRISPR-Cas13a-customized RNA nanococoons for spatial-controlled genome editing and precise cancer therapy.
Fan N; Bian X; Li M; Chen J; Wu H; Peng Q; Bai H; Cheng W; Kong L; Ding S; Li S; Cheng W
Sci Adv; 2022 May; 8(20):eabn7382. PubMed ID: 35584220
[TBL] [Abstract][Full Text] [Related]
6. Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma.
Wu Y; Jin W; Wang Q; Zhou J; Wang Y; Tan Y; Cui X; Tong F; Yang E; Wang J; Kang C
Mol Ther; 2021 Nov; 29(11):3305-3318. PubMed ID: 34274537
[TBL] [Abstract][Full Text] [Related]
7. Foldback-crRNA-Enhanced CRISPR/Cas13a System (FCECas13a) Enables Direct Detection of Ultrashort sncRNA.
Chen Y; Zhang Y; Luo S; Yang X; Liu C; Zhang Q; Liu Y; Zhang X
Anal Chem; 2023 Oct; 95(42):15606-15613. PubMed ID: 37824705
[TBL] [Abstract][Full Text] [Related]
8. A rapid and efficient platform for antiviral crRNA screening using CRISPR-Cas13a-based nucleic acid detection.
Yang L; Zhang Y; Yi W; Dong X; Niu M; Song Y; Han Y; Li H; Sun Y
Front Immunol; 2023; 14():1116230. PubMed ID: 37228594
[TBL] [Abstract][Full Text] [Related]
9. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.
Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y
Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251
[TBL] [Abstract][Full Text] [Related]
10. Dual-Locking Nanoparticles Disrupt the PD-1/PD-L1 Pathway for Efficient Cancer Immunotherapy.
Zhang Z; Wang Q; Liu Q; Zheng Y; Zheng C; Yi K; Zhao Y; Gu Y; Wang Y; Wang C; Zhao X; Shi L; Kang C; Liu Y
Adv Mater; 2019 Dec; 31(51):e1905751. PubMed ID: 31709671
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
12. RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
East-Seletsky A; O'Connell MR; Burstein D; Knott GJ; Doudna JA
Mol Cell; 2017 May; 66(3):373-383.e3. PubMed ID: 28475872
[TBL] [Abstract][Full Text] [Related]
13. A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment.
Zhao X; Liu L; Lang J; Cheng K; Wang Y; Li X; Shi J; Wang Y; Nie G
Cancer Lett; 2018 Sep; 431():171-181. PubMed ID: 29870774
[TBL] [Abstract][Full Text] [Related]
14. Programming the
Liu X; Kang X; Lei C; Ren W; Liu C
Anal Chem; 2022 Mar; 94(9):3987-3996. PubMed ID: 35193353
[TBL] [Abstract][Full Text] [Related]
15. Tetrahedron supported CRISPR/Cas13a cleavage for electrochemical detection of circular RNA in bladder cancer.
Cheng L; Yang F; Zhao Y; Liu Z; Yao X; Zhang J
Biosens Bioelectron; 2023 Feb; 222():114982. PubMed ID: 36493719
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas13a system: A novel tool for molecular diagnostics.
Zhao L; Qiu M; Li X; Yang J; Li J
Front Microbiol; 2022; 13():1060947. PubMed ID: 36569102
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas13a based bacterial detection platform: Sensing pathogen Staphylococcus aureus in food samples.
Zhou J; Yin L; Dong Y; Peng L; Liu G; Man S; Ma L
Anal Chim Acta; 2020 Aug; 1127():225-233. PubMed ID: 32800128
[TBL] [Abstract][Full Text] [Related]
18. A Multifunction Lipid-Based CRISPR-Cas13a Genetic Circuit Delivery System for Bladder Cancer Gene Therapy.
Fan J; Liu Y; Liu L; Huang Y; Li X; Huang W
ACS Synth Biol; 2020 Feb; 9(2):343-355. PubMed ID: 31891494
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
[TBL] [Abstract][Full Text] [Related]
20. Development of efficient, sensitive, and specific detection method for Encephalomyocarditis virus based on CRISPR/Cas13a.
Wei N; Xiong J; Ma J; Ye J; Si Y; Cao S
J Virol Methods; 2022 Nov; 309():114592. PubMed ID: 35905814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
